38 results on '"Mukherjee, Kakoli"'
Search Results
2. Assays, Surrogates, and Alternative Technologies for a TB Lead Identification Program Targeting DNA Gyrase ATPase
3. Discovery of MDV6058 (PF-06952229), a selective and potent TGFβR1 inhibitor: Design, synthesis and optimization
4. Screening, Identification, and Characterization of Mechanistically Diverse Inhibitors of the Mycobacterium Tuberculosis Enzyme, Pantothenate Kinase (CoaA)
5. Discovery of Novel Tgf-Βr1 Inhibitors as Potential Cancer Immunotherapy Agents
6. Essentiality and functional analysis of type I and type III pancolienate kinases of Mycobacterium tuberculosis
7. Proteins released during high toxin production in Clostridium difficile
8. Alteration in template recognition byEscherichia coli RNA polymerase lacking the ω subunit: A mechanistic analysis through gel retardation and foot-printing studies
9. Alteration in template recognition by Escherichia coli RNA polymerase lacking the ω subunit: A mechanistic analysis through gel retardation and foot-printing studies
10. Design, synthesis and optimization of bis-amide derivatives as CSF1R inhibitors
11. Abstract B30: Talazoparib efficacy is enhanced by noncytotoxic doses of temozolomide-mediated DNA damage in prostate cancer cell lines
12. Discovery of Imidazo[1,2-a]pyridine Ethers and Squaramides as Selective and Potent Inhibitors of Mycobacterial Adenosine Triphosphate (ATP) Synthesis
13. Pharmacological inhibition of cathepsin K: A promising novel approach for postmenopausal osteoporosis therapy
14. Synthesis and structure activity relationship of imidazo[1,2-a]pyridine-8-carboxamides as a novel antimycobacterial lead series
15. Scaffold morphing leading to evolution of 2,4-diaminoquinolines and aminopyrazolopyrimidines as inhibitors of the ATP synthesis pathway
16. Triaminopyrimidine is a fast-killing and long-acting antimalarial clinical candidate
17. Assessment of Mycobacterium tuberculosis Pantothenate Kinase Vulnerability through Target Knockdown and Mechanistically Diverse Inhibitors
18. Optimization of Pyrrolamides as Mycobacterial GyrB ATPase Inhibitors: Structure-Activity Relationship andIn VivoEfficacy in a Mouse Model of Tuberculosis
19. Aminoazabenzimidazoles, a Novel Class of Orally Active Antimalarial Agents
20. Assessment of Mycobacterium tuberculosis Pantothenate Kinase Vulnerability through Target Knockdown and Mechanistically Diverse Inhibitors
21. Novel N-Linked Aminopiperidine-Based Gyrase Inhibitors with Improved hERG and in Vivo Efficacy against Mycobacterium tuberculosis
22. Optimization of Pyrrolamides as Mycobacterial GyrB ATPase Inhibitors: Structure-Activity Relationship and In Vivo Efficacy in a Mouse Model of Tuberculosis
23. Structural and biochemical characterization of compounds inhibiting Mycobacterium tuberculosis Pantothenate Kinase
24. Alteration in template recognition by Escherichia coli RNA polymerase lacking the \omega subunit: A mechanistic analysis through gel retardation and foot-printing studies
25. Structural and Biochemical Characterization of Compounds Inhibiting Mycobacterium tuberculosis Pantothenate Kinase
26. Peptide deformylase inhibitors of Mycobacterium tuberculosis: Synthesis, structural investigations, and biological results
27. Peptide Deformylase Inhibitors as Potent Antimycobacterial Agents
28. Expression of Clostridium difficile Toxins A and B and Their Sigma Factor TcdD Is Controlled by Temperature
29. Aminoazabenzimidazoles, aNovel Class of Orally ActiveAntimalarial Agents.
30. GroEL is involved in activation of Escherichia coli RNA polymerase devoid of the omega subunit in vivo
31. Studies on the ω Subunit of Escherichia Coli RNA Polymerase
32. Assessment of Mycobacterium tuberculosisPantothenate Kinase Vulnerability through Target Knockdown and Mechanistically Diverse Inhibitors
33. Optimization of Pyrrolamides as Mycobacterial GyrB ATPase Inhibitors: Structure-Activity Relationship and In VivoEfficacy in a Mouse Model of Tuberculosis
34. GroEL is involved in activation of Escherichia coli RNA polymerase devoid of the ω subunit in vivo.
35. Screening, Identification, and Characterization of Mechanistically Diverse Inhibitors of the Mycobacterium TuberculosisEnzyme, Pantothenate Kinase (CoaA)
36. Expression of Clostridium difficileToxins A and B and Their Sigma Factor TcdD Is Controlled by Temperature
37. Alteration in template recognition byEscherichia coliRNA polymerase lacking the ω subunit: A mechanistic analysis through gel retardation and foot-printing studies
38. Optimization of Pyrrolamides as Mycobacterial GyrB ATPase Inhibitors: Structure-Activity Relationship and In VivoEfficacy in a Mouse Model of Tuberculosis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.